Data / Drug companies / Vitamin B6 Analog
Vitamin B6 Analog drugs: 5 drugs from 42 companies in the FDA NDC directory
Vitamin B6 Analog is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 162 products in this class from 42 companies, covering 5 drugs by generic name. The main marketing category is other unapproved drugs, and the newest product started marketing on October 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 42Companies
- 162Products
- 5Drugs by generic name
Drugs in the Vitamin B6 Analog class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Sodium fluoride | 3 | 124 |
| Folic acid | 7 | 34 |
| Doxylamine succinate and pyridoxine hydrochloride | 5 | 4 |
| Pyridoxine hci | 1 | 1 |
| Pyridoxine hydrochloride | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| PureTek Corporation | 38 | tablet; tablet, chewable | Other unapproved drugs | August 21, 2026 |
| Oncora Pharma, LLC | 10 | tablet; capsule | Other unapproved drugs | October 22, 2026 |
| Avion Pharmaceuticals, LLC | 8 | capsule, gelatin coated; tablet, coated | Other unapproved drugs | November 18, 2014 |
| Bryant Ranch Prepack | 8 | tablet, chewable; tablet, delayed release | Other unapproved drugs | December 19, 2019 |
| Method Pharmaceuticals, LLC | 7 | tablet, chewable; liquid | Other unapproved drugs | October 1, 2018 |
| Deseret Biologicals, Inc. | 6 | liquid | Unapproved homeopathic products | April 8, 2025 |
| Energetix Corporation | 6 | liquid | Unapproved homeopathic products | November 3, 2017 |
| Acella Pharmaceuticals, LLC | 5 | capsule, gelatin coated; capsule, coated | Other unapproved drugs | October 1, 2010 |
| Bryant Ranch Prepack | 5 | tablet, chewable; tablet, delayed release | Other unapproved drugs | December 19, 2019 |
| Professional Complementary Health Formulas | 5 | liquid | Unapproved homeopathic products | August 15, 1984 |
| Carwin Pharmaceutical Associates, LLC | 4 | tablet, chewable; capsule, liquid filled | Other unapproved drugs | June 1, 2015 |
| Dna Labs, Inc. | 4 | solution | Unapproved homeopathic products | January 1, 1990 |
| Exeltis USA, Inc. | 4 | capsule, liquid filled; capsule, gelatin coated | Other unapproved drugs | March 15, 2020 |
| Guna Spa | 4 | solution/ drops; pellet | Unapproved homeopathic products | May 27, 2010 |
| BioActive Nutritional, Inc. | 3 | liquid; spray | Unapproved homeopathic products | January 2, 2020 |
| BonGeo Pharmaceuticals, Inc. | 3 | tablet, chewable | Other unapproved drugs | September 10, 2015 |
| Nucleic Products, LLC | 3 | liquid | Unapproved homeopathic products | May 21, 2024 |
| Nutritional Specialties, Inc. | 3 | liquid; spray | Unapproved homeopathic products | November 21, 2023 |
| Seton Pharmaceuticals | 3 | tablet, chewable; capsule, gelatin coated | Other unapproved drugs | October 1, 2009 |
| U.S. Pharmaceutical Corporation | 3 | capsule; capsule, liquid filled | Other unapproved drugs | June 24, 2009 |
| Winder Laboratories LLC | 3 | tablet, chewable | Other unapproved drugs | December 1, 2023 |
| Duchesnay USA, Inc. | 2 | tablet, extended release; tablet, delayed release | New drug applications (NDA) | February 19, 2018 |
| Energique, Inc. | 2 | liquid | Unapproved homeopathic products | February 18, 2026 |
| Hillestad Pharmaceuticals USA | 2 | tablet, coated | Other unapproved drugs | May 1, 2008 |
| Meditrend, Inc. DBA Progena Professional Formulations | 2 | liquid | Unapproved homeopathic products | September 15, 2025 |
| Remedyrepack Inc. | 2 | tablet | Other unapproved drugs | January 20, 2025 |
| Womens Choice Pharmaceuticals LLC | 2 | tablet, film coated; capsule, gelatin coated | Other unapproved drugs | July 20, 2017 |
| A-S Medication Solutions | 1 | tablet | Other unapproved drugs | April 1, 2013 |
| Actavis Pharma, Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | June 21, 2019 |
| Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals | 1 | powder | Other unapproved drugs | March 22, 2024 |
| Analog Pharma | 1 | tablet, delayed release | Authorized generics (NDA) | November 15, 2018 |
| Bionpharma Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | December 11, 2023 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | August 14, 1972 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection, solution | Generic drugs (ANDA) | October 8, 2019 |
| Lydia Co., Ltd. | 1 | liquid | Other unapproved drugs | January 23, 2023 |
| Mission Pharmacal Company | 1 | tablet | Other unapproved drugs | April 11, 2014 |
| Mylan Institutional LLC | 1 | injection | Other unapproved drugs | May 10, 2013 |
| Par Health USA, LLC | 1 | tablet, delayed release | Generic drugs (ANDA) | December 19, 2019 |
| Patrin Pharma, Inc. | 1 | tablet | Other unapproved drugs | April 1, 2013 |
| ProBLEN | 1 | liquid | Unapproved homeopathic products | April 15, 2021 |
| Skya Health, LLC | 1 | capsule, gelatin coated | Other unapproved drugs | September 4, 2026 |
| V2 Pharma, LLC | 1 | capsule | Other unapproved drugs | May 16, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 45 | 27.8% |
| Liquid | 33 | 20.4% |
| Tablet, chewable | 31 | 19.1% |
| Capsule, gelatin coated | 12 | 7.4% |
| Capsule | 8 | 4.9% |
| Tablet, delayed release | 7 | 4.3% |
| Solution | 4 | 2.5% |
| Capsule, liquid filled | 4 | 2.5% |
| Tablet, film coated | 3 | 1.9% |
| Tablet, coated | 3 | 1.9% |
| Solution/ drops | 2 | 1.2% |
| Pellet | 2 | 1.2% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.